August 10, 2023
FTC Revamps the “Guides Concerning the Use of Endorsements and Testimonials in Advertising”
June 30, 2023
FDA Finalizes Guidance on Presenting Quantitative Efficacy and Risk Information in DTC Promotion
April 1, 2023
Chambers Global Practice Guide: Pharmaceutical Advertising 2023
January 23, 2023
2022 Year in Review: FDA Drug and Device Advertising and Promotion Enforcement
March 21, 2022
Chambers Global Practice Guide: Pharmaceutical Advertising 2022
August 6, 2021
FDA Finalizes “Intended Use” Regulations
March 19, 2021
Pharmaceutical Advertising
September 24, 2020
FDA Proposes New Rule Modifying its “Intended Use” Regulations
January 26, 2017
FDA Defends Its First Amendment Position in “Memorandum”
January 20, 2017
FDA Issues Draft Guidance Addressing Communications with Payors
January 19, 2017
FDA Takes Action in the Last Days of the Obama Administration to Clarify Some of Its Views on Off-Label Communications
March 17, 2016
2015 Year in Review: Drug Promotion Warning Letters